The role of long-term alcohol consumption for the risk of developing ulcerative colitis (UC) and Crohn's disease (CD) is unclear. For the first time, to prospectively assess the role of pre-disease alcohol consumption on the risk of developing UC or CD. SUBJECTS/METHODS: Nested within the European Prospective Investigation into Cancer and Nutrition (EPIC-IBD), incident UC and CD cases and matched controls where included. At recruitment, participants completed validated food frequency and lifestyle questionnaires. Alcohol consumption was classified as either: non-use, former, light (⩽0.5 and 1 drink per week), below the recommended limits (BRL) (⩽1 and 2 drinks per day), moderate (⩽2.5 and 5 drinks per day), or heavy use (42.5 and 45 drinks per day) for women and men, respectively; and was expressed as consumption at enrolment and during lifetime. Conditional logistic regression was applied adjusting for smoking and education, taking light users as the reference. RESULTS: Out of 262 451 participants in six countries, 198 UC incident cases/792 controls and 84 CD cases/336 controls were included. At enrolment, 8%/27%/32%/23%/11% UC cases and 7%/29%/40%/19%/5% CD cases were: non-users, light, BRL, moderate and heavy users, respectively. The corresponding figures for lifetime non-use, former, light, BRL, moderate and heavy use were: 3%/5%/23%/44%/19%/6% and 5%/2%/25%/44%/23%/1% for UC and CD cases, respectively. There were no associations between any categories of alcohol consumption and risk of UC or CD in the unadjusted and adjusted odds ratios. CONCLUSION: There was no evidence of associations between alcohol use and the odds of developing either UC or CD.
INTRODUCTION
The aetiology of the inflammatory bowel diseases (IBD), namely Crohn's disease (CD) and ulcerative colitis (UC), is largely unknown, but may involve a dysfunctional immune response to the gut microbiota in those with a genetic susceptibility. 1 The contribution of genetic risk loci in association with IBD was estimated at o 25%, 2 leading to the assumption that environmental factors have an important role in aetiology. Among investigated environmental factors showing associations so far are: dietary intakes of fatty acids, protein, meat, sugars, fibre and fruits, physical activity and cigarette smoking. [3] [4] [5] Alcohol consumption is a ubiquitous lifestyle factor in European societies closely related to these and other dietary and lifestyle factors. 6, 7 Hypothetically alcohol consumption may be related to IBD via several biological paths. For instance, the consumption of alcoholic beverages could have opposing effects on the gut mucosa, as ethanol can cause intestinal mucosal injury and increase bacterial translocation. 8 Alternatively, some components of alcoholic beverages such isoflavones could potentially have antioxidant and probiotical proprieties and possibly modulate the intestinal inflammatory bowel response. 9 In patients with established IBD, [10] [11] [12] [13] clinical studies have reported that alcohol consumption provoked symptoms or increased biomarkers of relapse in inactive disease, 14 and this could explain why patients with IBD avoid its use 15 and why alcohol-related causes of death are less frequent in IBD patients. 16, 17 Only a few case-control studies have investigated alcohol consumption, often in combination with smoking and diet, in the aetiology of IBD and have reported inconsistent results. For UC, no associations were documented in Chinese and Swedish populations, 18, 19 but there was an inverse association in alcohol users compared with non-users or infrequent users, in US American and Japanese populations. [20] [21] [22] [23] Epidemiological studies investigating alcohol consumption and the development of CD are scarce; one showing consuming alcohol at least once per week lowered the risk 24 and another reporting no association for use of alcoholic beverages. 25 Limitations of all these retrospective studies, where that they relied on self-reports of recalled previous alcohol use, which in cases may have been after establishment of the IBD diagnosis rather than before the onset of symptoms, hence introducing recall bias. In prospective cohort studies, where initially healthy people report their diet and alcohol consumption and are then followed up to identify those who develop IBD, recall and selection biases are reduced. To date, no prospective epidemiological study has investigated the lifetime use of alcohol on the development of UC or CD. We aimed to address this by assessing whether there is an association between alcohol consumption at several time points during a participant's lifetime prior to the recruitment into the multi-centre European Prospective Investigation into Cancer and Nutrition (EPIC-IBD) study and the subsequent development of UC or CD.
MATERIALS AND METHODS
The EPIC study recruited~520 000 participants during the years 1992 until 2000 namely women and men mainly ages 35 to 65 and 40 to 65 years in 23 collaborating centres in 10 European countries to investigate the role of diet and other lifestyle factors in the aetiology of cancer and other chronic diseases in a general population with a prospective study design. 26 At recruitment, participants completed questionnaires on diet and lifestyle factors, medical history and underwent anthropometric examinations in each centre. The study was approved in each centre by the relevant local ethics committee and each participant gave written consent.
The EPIC-IBD study was embedded in a sub-cohort of EPIC involving 401 326 initially healthy women and men without UC or CD, in the age range 20 to 80 years, recruited from 12 centres in eight European countries. Information on lifetime use of alcohol was not collected in all these centres, hence the study population was 262 451 participants in 7 centres in 6 European countries ( Table 1 ). The sub-cohorts were followed up until at least May 2004 and in some centres until December 2010 where incident cases of UC and CD were identified by several methods including national and regional IBD registries, follow-up questionnaires and hospital databases ( Table 1 ). All the medical records of potential cases were reviewed to obtain information from radiological, endoscopic and histological reports to confirm the diagnoses and to document the extent of the disease in the gastrointestinal tract. Prevalent cases at recruitment and all cases of microscopic colitis were excluded. A nested case-control study design within the EPIC-IBD cohort was performed. Each case was matched with four randomly selected controls free of IBD and alive at the date of diagnosis of the case. The matching criteria were: age at enrolment (±6 months), gender, centre and enrolment date (±3 months). There were 2 UC controls and 2 CD controls where the FFQ-data on alcohol consumption at baseline was missing which is why they were excluded from this analysis ( Table 1) .
Alcohol use was assessed as previously described. 27 At enrolment, alcohol consumption during the previous 12 months was recorded using validated country-specific food frequency questionnaires (FFQs), and in a standardised lifestyle questionnaire, participants reported on their habitual consumption of alcoholic beverages per week when they were 20, 30, 40 or 50 years old. Glasses of alcoholic beverages reported in both questionnaires were converted into grams of alcohol per day (g per day) by applying empirically derived definitions of standard drinks for each beverage and country of EPIC. 28 According to the amount of alcohol intake at enrolment, the participants (women and men, respectively) were classified into either: non-user, light user (40-1 and 40-2 g per day; corresponding to 0.5 and 1 drink per week), below the recommended limits (BRL) user (41-12 and 42-24 g per day; corresponding up to 1 and 2 drinks per day), moderate user (412-30 and 424-60 g per day; corresponding to 1-2 and 2-5 drinks per day) and heavy user (430 and 460 g per day; corresponding to 42.5 and 45 drinks per day). [29] [30] [31] According to the recall of consumption in the years previous to enrolment, average lifetime alcohol consumption was determined as a weighted average of intake at different ages, with weights equal to the time of individual exposure to alcohol at different ages; categories of alcohol use were then defined as described above. Never drinkers were those participants who did not report any consumption of alcoholic beverages at all points during their lifetime, while those who reported alcohol consumption at ages 20, 30, 40 or 50 years, but not during the 12 month prior to the recruitment were categorised as former users. 32 Finally, the lifetime pattern of alcohol use was assessed taking variation over time into account; alcohol consumers at enrolment were classified according to the highest level ever reached into 'lifetime light' (always being a light user), 'lifetime BRL' (all points in time using alcohol maximally BRL), 'lifetime light to moderate' (all points in time using alcohol maximally moderately), and 'lifetime occasionally or always heavy'. [29] [30] [31] The self-completed questionnaires recorded: educational level and smoking status including the number of cigarettes. Information on dietary intake was derived from the FFQ, namely nine categories of consumption frequencies which varied from never to several times per day for approximately 200 food items. Using national databases of food composition from the EPIC-nutrient database, the 24 hr intake of total energy, food groups and individual nutrients were calculated. 33 Conditional logistic regression was applied to calculate odds ratios (OR) and 95% confidence intervals (95% CI) for alcohol consumption at enrolment, during lifetime in average and for the lifetime pattern of alcohol use and the development of UC or CD. Light alcohol users (⩽1 and ⩽ 2 g per day) were chosen as the reference group, as non-users may have heterogeneous reasons for abstention including health problems related to the diseases of interest and thus feigning a potential beneficial effect of alcohol use. 34, 35 Models were either unadjusted or adjusted for smoking status (never smoker, former smoker and smoker at enrolment), smoking duration, and educational attainment. As the intake of polyunsaturated fatty acids (PUFAs) were associated with UC in an earlier analysis, 36 sensitivity analyses were performed, additionally adjusting the models of UC and CD for decosahexaenoic (n-3 PUFA) and linoleic acid (n-6 PUFA) (g per day, continuously), as well as excluding cases diagnosed within 18 months after enrolment (to assess the possibility of reverse causation), and running the models separately for men and women.
All analyses were performed using the statistical software SAS (Version 9.4, Enterprise Guide 6.1, SAS Institute Inc., Cary, NC, USA).
Epidemiological data analyses of EPIC, including EPIC-IBD, may be conducted upon application addressed to the Steering Committee of EPIC. Each application will have to pass a review process by a scientific board.
RESULTS
One hundred and ninety-eight UC and 84 CD incident cases and 792 matched UC controls and 336 matched CD-controls were included ( Table 2 ). The median time from recruitment to IBD diagnosis was around 3.5 years (UC: 3.7, interquartile range 2.4-5.6; CD 3.5, interquartile range 1.6-5.9 years). Participants who developed UC were on average 2 years older at the time of enrolment than those who developed CD. More women than men developed IBD (63% of UC cases and 81% of CD cases). The proportion of smokers at the time of enrolment, compared with their controls, was 32 and 24% (respectively) among CD cases, whereas for UC cases, the proportion of former smokers was 40% compared to 32% of controls. Alcohol consumption was common, with only about 7% of IBD cases and 9% of controls being nonusers at recruitment. According to lifetime average use half of the IBD cases as well as the UC controls consumed less than about 7-8 g per day alcohol. The median and the range of average alcohol consumption during lifetime were lowest among CD controls. About 3% of the UC cases and controls, and about 5 and 7% of the CD cases and controls never used alcohol during lifetime. Most of the IBD cases and controls (about 77-83%) used alcohol during lifetime, although never heavily. Table 3 shows the ORs for UC and CD according to the three assessments of alcohol consumption used in this study. There were no associations for the development of UC or CD according to either: alcohol consumption at recruitment, lifetime average alcohol use or pattern of lifetime alcohol use compared with participants with light alcohol consumption. Odds ratios were similar when the models were either not adjusted or adjusted for smoking and education. Additional adjustment of the models for dietary fatty acids, namely linoleic and decosahexaenoic acid, the exclusion of the cases diagnosed within the 18 months of followup and the separate calculation of the OR for women and men did not change the results.
DISCUSSION
This prospective study found there were no associations between alcohol consumption and the development of either UC or CD neither at recruitment, nor during lifetime from 20 years of age onwards or for any lifetime patterns of alcohol use. The findings were similar for abstention from or cessation of alcohol use at some time point before recruitment.
The literature previously discussed a role of the microbiota, genetics, diet and lifestyle, and other environmental factors in the aetiology of IBD. [37] [38] [39] Alcohol use is part of socio-cultural life and part of dietary patterns, and its consumption has been reported to be increasing over the last decades in many European populations. 40 Therefore, it was hypothesised that alcohol may influence inflammatory responses in the gastrointestinal tract as it can cause direct mucosal injury as well as increasing bacterial translocation 8 and therefore increase the risk for IBD. Epidemiological studies on the role of alcohol in the aetiology of IBD are scarce, [18] [19] [20] [23] [24] [25] and consist of only retrospective case-control investigations, which studied 167 to 384 UC cases and 58 to 315 CD cases. These observational studies retrospectively collected information on alcohol consumption before the onset of symptoms for disease, and reported either: lower risk for regular alcohol users compared with little or non-users, 20, 23 no associations 19, 24 or the associations disappeared when controlling for smoking, appendectomy or other confounders. 18, 25 Our study is the first to prospectively investigate alcohol consumption and the subsequent development of IBD, nested in EPIC, an Europeanwide cohort multi-centre study investigating diet and the development of cancer and other chronic diseases with over half a million participants in 10 countries.
The strength of our study is the prospective design of the data collection and the coverage of a large part of the European population to which the results are generalisable. The information on how alcohol was used during lifetime was recalled, but was collected before participants developed the symptoms of IBD or were diagnosed with the illness. Self-reported use of alcohol is prone to recall bias and social desirability bias; 41 nevertheless, the assessment of lifetime consumption at the time of recruitment in prospective studies was reliable in studies on weight development 32 and mortality. 27 Owing to the prospective recruitment, and the use of standardised FFQ and lifestyle questionnaires, we were able to adjust the models for variables that may be relevant for the development of IBD and also may be related to alcohol consumption (education, smoking and polyunsaturated fatty acids). We used light alcohol users as reference because these participants in general tolerate alcohol; but its consumption is less likely to have any metabolic effect related to health. If the reference group were never-users, these may have several reasons for abstention including health problems related to the diseases of interest and thus feigning a potential beneficial effect of alcohol use. [42] [43] [44] A further strength of our study is that we included incident cases, which were medically verified, and that we performed a sensitivity analysis excluding those cases diagnosed Alcohol use and risk of IBD MM Bergmann et al early during the follow-up, to avoid including possible prevalent cases in the models.
Our study has limitations. First is the relatively low number of cases of IBD compared with recently published numbers from a cohort in Europe. 45 The relatively small numbers of cases and the older age of our study population may limit our findings to IBD cases that occur later in life and are therefore not generalisable to the group of persons where the disease emerges at younger ages. However, the number of cases we identified was comparable to that of a previous cohort study (EC-IBD) which recruited new IBD cases in 1991-93, the same time the EPIC study recruited participants, 46 suggesting that our procedures of identification of cases were equivalent. Second, due to the demographic nature of the EPIC study, the number of cases diagnosed in young is low (the median age at diagnosis of our cases is more than 15 years older than that reported for Europe 45 ). Nevertheless, it can be supposed that in early-age and young-age the genetic factors may have a more relevant role than environmental factors in the aetiology of IBD, and IBD in adulthood may be more influenced by the latter. 38 Therefore, the potential influence of alcohol use in IBD pathogenesis would be greater in an adult cohort, such as ours. Thirdly, the assessment of alcohol consumption was only performed at the enrolment of participants, and not surveyed prospectively. Therefore, it is not possible to know if participants changed their alcohol habits during follow-up and if this might have any influence in the risk of IBD. However, as half of the cases were diagnosed during the first 3.5 years of follow-up, it is conceivable that factors reported at recruitment are still related to disease development. Alcohol consumption was reported to be increasing over the last decades in many European populations, 40 together with an increase in the incidence of IBD, 45 although our results would suggest the two are not associated.
In conclusion, our data does not support a role for alcohol consumption in the aetiology of either UC or CD. 
